George Painter, president of the Emory Institute for Drug Development, Emory University, is also cautious about the HIV protease inhibitor strategy. “It’s probably a long shot to go for drug repurposing activity against the coronavirus using HIV drugs; these were protease inhibitors that were designed specifically for HIV,” he says.

Они что - в слепую стреляют на всякий случай?